GENETIC ENGINEERING AS A DRIVER OF EXPORT COMPETITIVENESS IN SOUTH AFRICA’S MEDICAL CANNABIS SECTOR

Globally, the medicinal cannabis industry is undergoing rapid transformation, with international competitiveness increasingly shaped by genomic precision and biotechnological innovation. Leading producers such as Canada, Israel and the Netherlands have used genetic tools, from genomic characterisation and marker-assisted breeding to clonal propagation of genetically defined cultivars, to supply standardised products that meet pharmaceutical requirements. South Africa's progress, however, has been constrained by fragmented legislation, complex licensing systems and limited investment in research and development. Existing literature has largely focused on therapeutic discoveries and strain stabilisation in developed contexts, leaving a gap in understanding how emerging economies can integrate indigenous germplasm into global value chains. Using a structured integrative literature review reported according to PRISMA 2020 principles, and anchored in Regulatory Governance Theory and Global Value Chain analysis, this article investigates how genetic engineering can enhance the export competitiveness of South Africa's medical cannabis sector. The findings show that genetic engineering, understood as a staged pathway from genomic characterisation and marker-assisted breeding to genome editing, is the principal driver of product upgrading and export competitiveness, but that its effect is institutionally conditioned. South Africa's landraces remain uncharacterised, and coordination, regulatory and analytical capacities are dispersed across at least five state institutions, so the binding constraint is governance rather than science. The article contributes a sequenced governance model that enables genetic engineering while protecting biosafety and benefit-sharing, positioning South Africa within debates on indigenous resource protection and industrial upgrading.

Authors

Publication Details

Journal
Ayika.
Published
2026-11-18
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GENETIC ENGINEERING AS A DRIVER OF EXPORT COMPETITIVENESS IN SOUTH AFRICA’S MEDICAL CANNABIS SECTOR

Costa Hofisi,  Barbara Ziyane, Mahlatse Sevhake
Ayika.
Biotechnology and Related Fields
article

GENETIC ENGINEERING AS A DRIVER OF EXPORT COMPETITIVENESS IN SOUTH AFRICA’S MEDICAL CANNABIS SECTOR

Costa Hofisi,  Barbara Ziyane, Mahlatse Sevhake
article en

Abstract

Globally, the medicinal cannabis industry is undergoing rapid transformation, with international competitiveness increasingly shaped by genomic precision and biotechnological innovation. Leading producers such as Canada, Israel and the Netherlands have used genetic tools, from genomic characterisation and marker-assisted breeding to clonal propagation of genetically defined cultivars, to supply standardised products that meet pharmaceutical requirements. South Africa's progress, however, has been constrained by fragmented legislation, complex licensing systems and limited investment in research and development. Existing literature has largely focused on therapeutic discoveries and strain stabilisation in developed contexts, leaving a gap in understanding how emerging economies can integrate indigenous germplasm into global value chains. Using a structured integrative literature review reported according to PRISMA 2020 principles, and anchored in Regulatory Governance Theory and Global Value Chain analysis, this article investigates how genetic engineering can enhance the export competitiveness of South Africa's medical cannabis sector. The findings show that genetic engineering, understood as a staged pathway from genomic characterisation and marker-assisted breeding to genome editing, is the principal driver of product upgrading and export competitiveness, but that its effect is institutionally conditioned. South Africa's landraces remain uncharacterised, and coordination, regulatory and analytical capacities are dispersed across at least five state institutions, so the binding constraint is governance rather than science. The article contributes a sequenced governance model that enables genetic engineering while protecting biosafety and benefit-sharing, positioning South Africa within debates on indigenous resource protection and industrial upgrading.

Ayika.
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon